"A coordinated, multidisciplinary approach integrating digital monitoring, community diversion, and alternative treatment pathways effectively maintained ED operational resilience during a public health crisis" Seak et al (2026).

ED-based outpatient parenteral antimicrobial therapy program

Abstract:

Background: Emergency department (ED) overcrowding and boarding intensified during the COVID-19 pandemic. We evaluated the association of a multidisciplinary rapid response team (RRT) with ED boarding during the 2021 surge in New Taipei City, Taiwan.

Methods: A retrospective quality improvement study was conducted at a 1058-bed, newly established tertiary referral hospital situated at the epicenter of the pandemic in Taiwan. In May 2021, an RRT implemented three strategies: (1) diversion of mild COVID-19 cases to quarantine centers via telemedicine, (2) real-time business intelligence (BI) dashboard monitoring for bed allocation, and (3) an ED-based outpatient parenteral antimicrobial therapy (OPAT) program. Primary outcomes were ED boarding time and the proportion of stays exceeding 48 h.

Results: Among 43,368 ED visits in 2021, median ED boarding time decreased from 58.4 h (IQR 42.2-76.8) during the pre-intervention period to 6.2 h (IQR 4.1-11.5) following RRT implementation (P < .001). The proportion of patients boarding >48 h decreased from 5.09% in June to 0.16% in December 2021.

Conclusion: A coordinated, multidisciplinary approach integrating digital monitoring, community diversion, and alternative treatment pathways effectively maintained ED operational resilience during a public health crisis. This model offers an adaptable operational strategy for managing acute capacity strain and maintaining throughput during future epidemic surges.


Reference:

Seak CJ, Goh ZNL, Cheng HT; SPOT Investigators. Mitigating ED boarding during surge conditions: A multidisciplinary resilience model at a tertiary center epicenter. Am J Emerg Med. 2026 Aug 18;110:123-128. doi: 10.1016/j.ajem.2026.08.027. Epub ahead of print. PMID: 42628316.